Suzetrigine (Journavx) is the first non-opioid pain medication to be approved in the US in 20 years. It could help over 80 million Americans living with severe acute pain, while reducing the effects of the opioid crisis.

Source: https://www.dw.com/en/us-health-agency-approves-brand-new-painkiller/a-71472992?maca=en-rss-en-all-1573-rdf